Tisch MS News

Journal Club: May 10, 2013

Kristi Clark (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of b-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis Reference: J.L. Grant, E.E.B. Ghosn, R.C...

May 10, 2013

More

Journal Club: July 12, 2013

Violaine Harris (Tisch MSRCNY) presented the following article in Journal Club. Article Title: A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis Reference: S.D. Shields, PhD, X. Cheng, PhD, A. Gasser, PhD, C.Y. Saab, PhD, L. Tyrrell, MS, E.M. Eastman, BS, M...

July 12, 2013

More

Stem Cell Trial Update: July 15th, 2013

Tisch MS Research Center of New York has formally submitted a response to the Food and Drug Administration’s (FDA) clinical hold on our proposed Phase I trial of Mesenchymal Stem Cell-Derived Neural Progenitors in the treatment of multiple sclerosis. Per agency rules, this submission necessitates a...

July 15, 2013

More

Tisch MS Researchers Announce Breakthrough in Disease Monitoring

A Research team lead by Violaine Harris, Ph.D., at the Tisch MS Research Center of New York, has just published findings on a new method of measuring disease activity in patients with multiple sclerosis (MS) (Harris, et al, Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis,...

July 26, 2013

More

FDA Approves MSC-NP Therapy as Investigational New Drug in MS Clinical Trial: A Research Milestone

The stem cell research division of the Tisch MS Research Center of New York proudly announces Food and Drug Administration (FDA) approval of autologous, mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) as an Investigational New Drug (IND) for an open label, phase I clinical trial in...

August 14, 2013

More

MS Discovery Forum Reports on FDA-IND Approval of Tisch MS Stem Cell Trial

Ricki Lewis, Ph.D., filed a report for the Multiple Sclerosis Discovery Forum on FDA approval for the upcoming clinical trial of MSC-NPs at the Tisch MS Research Center of New York. Lewis quotes multiple outside experts alongside Saud Sadiq, M.D., director of Tisch MS, on the science behind the...

September 16, 2013

More

Tisch MS Breakthrough in Biomarker Research Featured as Cover Article in October 2013 Issue of Multiple Sclerosis Journal

Multiple Sclerosis Journal has selected the recent Tisch MS publication " Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis ," co-authored by Violaine Harris, PhD, and Saud Sadiq, MD, among others, as its cover article for October 2013. This important biomarker discovery is...

September 24, 2013

More

Tisch MS Research Center Patient Symposium 2013 A Huge Success

Tisch MSRCNY welcomed almost 1,000 guests on Sunday, October 13, 2013 to the New York Hilton. We would like to thank our patients and supporters for making this a truly momentous event! The title of Dr. Sadiq’s talk, “What Does This Study Mean For Me?” signified an opportunity to answer many...

October 17, 2013

More

Thanksgiving 2013 Closure

Tisch MS Research Center of New York would like to advise patients and other interested parties that we will be closing at 2pm on Wednesday, November 27, and reopening on Monday, December 2, in observance of the Thanksgiving holiday.

November 22, 2013

More

Grand Rounds: December 4, 2013

Dr. Steven A. Goldman, MD, PhD, Co-Director of the Center for Translational Medicine and Professor in the Departments of Neurology and Neurosurgery at the University of Rochester School of Medicine and Dentistry, delivered the Grand Rounds lecture for December 4, 2013. Dr. Goldman's presentation...

December 4, 2013

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.